Status:
COMPLETED
Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)
Lead Sponsor:
Organon and Co
Conditions:
Asthma
Eligibility:
All Genders
18-55 years
Phase:
PHASE3
Brief Summary
This is a multicenter study to evaluate the efficacy and safety of MK0476 versus placebo in participants with chronic asthma who actively smoke cigarettes.
Eligibility Criteria
Inclusion
- Participants with chronic asthma who actively smoke at least 0.5 to no more than 2 packs of cigarettes a day
Exclusion
- Participant cannot have a diagnosis of Chronic Obstructive Pulmonary Disease (COPD) or emphysema.
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
1640 Patients enrolled
Trial Details
Trial ID
NCT00284856
Start Date
May 1 2006
End Date
April 1 2010
Last Update
May 10 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.